Robert J. Terifay, SVP Commercial at REGENERON PHARMACEUTICALS INC (REGN), sold 29,236 shares at $590.57 ($17.2M) on 2015-08-06, disclosed to the SEC on 2015-08-07.
Open-market sale of $17.2M REGN by SVP Commercial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $588.64 | 1,521 | $895K | 5.2% |
| 2 | $588.64 | 14,292 | $8.4M | 48.9% |
| 3 | $585.22 | 2,007 | $1.2M | 6.8% |
| 4 | $587.35 | 2,482 | $1.5M | 8.5% |
| 5 | $588.55 | 2,126 | $1.3M | 7.3% |
| 6 | $589.76 | 2,542 |
| $1.5M |
| 8.7% |
| 7 | $590.57 | 2,486 | $1.5M | 8.5% |
| 8 | $591.75 | 957 | $566K | 3.3% |
| 9 | $592.40 | 23 | $14K | 0.1% |
| 10 | $593.66 | 800 | $475K | 2.8% |
| Total | $588.79 avg | 29,236 | $17.2M | 100% |
| Filing → |
| REGN | SELL | 2015-02-25 | $4.7M | — | Filing → |
| REGN | SELL | 2014-11-19 | $9.1M | — | Filing → |
| REGN | SELL | 2014-02-19 | $4.3M | — | Filing → |